ESRP1 and cancer: Esrp1/2 exert an epithelial-specific splicing program that is reverted upon initiation of EMT (Warzecha et al., 2010; Yang et al., 2016), and Esrp1/2 are implicated in developmental processes and organogenesis, as well as cancer progression (Derham and Kalsotra, 2023).